144Filing Date: Aug 27, 2026

Vertex (VRTX)

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001958244-26-000559

Sale Plan

Bruce I. Sachs
Director·Vertex
Proposed
CommonNASDAQ
Shares1.21K
Est. DateAug 27
Market Value$662.5K
BrokerGoldman Sachs & Co. LLC
AcquisitionAcquired as a gift · Bruce I. Sachs & Kimberlie T. Sachs JTWROS
Acquired DateApr 13, 2023
Amount Acquired1.21K
% Outstanding0.0005%
Exercise / Payment Details
Paid: Apr 13, 2023Method: None
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 27, 2026
Signature Goldman Sachs & Co. LLC on behalf of Bruce I. Sachs
Issuer Info expand_more
CompanyVertex Pharmaceuticals Incorporated
CIK0000875320
SEC File No.000-19319
Phone1-617-341-6100
Address50 Northern Avenue, Boston, MA 02210

keid analysis is for reference only and does not constitute investment advice.